These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22072229)

  • 21. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
    Eggers KM; Lagerqvist B; Oldgren J; Venge P; Wallentin L; Lindahl B
    Am Heart J; 2008 Sep; 156(3):588-94. PubMed ID: 18760145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
    Palazzuoli A; Rizzello V; Calabrò A; Gallotta M; Martini G; Quatrini I; Campagna MS; Franci B; Nuti R
    Clin Chim Acta; 2008 May; 391(1-2):74-9. PubMed ID: 18328262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden.
    Niccoli G; Bacà M; De Spirito M; Parasassi T; Cosentino N; Greco G; Conte M; Montone RA; Arcovito G; Crea F
    Atherosclerosis; 2012 Jul; 223(1):166-70. PubMed ID: 22640815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study.
    Tajsic M; Járai R; Koch J; Stangl K; Wojta J; Dreger H; Huber K
    Int J Cardiol; 2018 Dec; 273():243-248. PubMed ID: 30282602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
    Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
    Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury.
    Cai XY; Lu L; Wang YN; Jin C; Zhang RY; Zhang Q; Chen QJ; Shen WF
    Atherosclerosis; 2011 Aug; 217(2):536-42. PubMed ID: 21663912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.
    García-García HM; Oemrawsingh RM; Brugaletta S; Vranckx P; Shannon J; Davies R; Boersma E; Serruys PW
    Atherosclerosis; 2012 Nov; 225(1):142-7. PubMed ID: 22963982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation.
    Falcone C; Bozzini S; D'Angelo A; Matrone B; Colonna A; Benzi A; Paganini EM; Falcone R; Pelissero G
    Dis Markers; 2013; 35(3):135-40. PubMed ID: 24167358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional role of soluble receptor for advanced glycation end products in stroke.
    Tang SC; Wang YC; Li YI; Lin HC; Manzanero S; Hsieh YH; Phipps S; Hu CJ; Chiou HY; Huang YS; Yang WS; Mattson MP; Arumugam TV; Jeng JS
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):585-94. PubMed ID: 23288172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
    Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
    Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable exclusion of acute coronary syndrome among hospitalized patients with elevated troponin.
    Davis MB; Shafton A; Desai A; Childers D; Bach DS
    Clin Cardiol; 2014 Jul; 37(7):395-401. PubMed ID: 25180409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of mean platelet volume in young patients with non-ST-segment elevation acute coronary syndromes: a retrospective observational study.
    Özlü MF; Öztürk S; Ayhan SS; Tosun M; Alçelik A; Erdem A; Yazici M
    Anadolu Kardiyol Derg; 2013 Feb; 13(1):57-61. PubMed ID: 23086804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.